IP Library Granted Patent US 9,427,399
Granted Patent B2
US 9,427,399 · App. 14/822,686 · Granted Aug 30, 2016

Process for making controlled release medical implant products

Inventors: Robert W. Adams (Oakton, VA); Wayne C. Pollock (Lincoln University, PA)
Assignee: Robert W. Adams
A61K9/0024A61K31/485B29C67/0059B29K2067/046B29K2995/0056B33Y10/00B33Y80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,427,399
App. No.
14/822,686
Granted
Aug 30, 2016
Kind
B2
Abstract

A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at least in part, computer-controlled 3-D printing equipment to deposit via nozzles portions of one or more layers of the medical implant product. The implant has an outer impervious coating, an inner matrix core, an opening and an optional bonding layer.

Claims (12)

1. A multi-step method of making a mammalian subcutaneous medical implant for releasing self-contained drugs on a controlled basis over at least a 3 day period wherein the method comprises depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer, wherein the method comprises a first step of supplying a sheet of prefabricated coating material.

2. A multi-step method of making a mammalian subcutaneous medical implant for releasing self-contained drugs on a controlled basis over at least a 3 day period wherein the method comprises depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer, wherein a matrix core layer is created, in whole or in part, within a separate chamber.

3. A multi-step method of making a mammalian subcutaneous medical implant for releasing self-contained drugs on a controlled basis over at least a 3 day period wherein the method comprises depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer, wherein more than one implant is formed at the same time, and wherein one or more layers of each of the implants are created at least in part by 3-D printing.

4. The method according to claim 3 , wherein at least one process step involves separating more than one implant at least in part by cutting, lasers, etching or mechanical devices.

5. The method according to claim 4 , wherein the separation step results in the creation of a large number of individual implants to increase yield or to reduce manufacturing expense.

6. A subcutaneous medical implant for releasing self-contained drugs on a controlled basis over at least a 3 day period wherein its method of manufacture involves, at least in part, the use of at least one computer controlled 3-D printer to deposit portions of one or more individual layers of the implant, wherein at least one layer of the implant is a sheet of prefabricated coating material.

7. A subcutaneous medical implant for releasing self-contained drugs on a controlled basis over at least a 3 day period wherein its method of manufacture involves, at least in part, the use of at least one computer controlled 3-D printer to deposit portions of one or more individual layers of the implant, wherein more than one implant is formed at the same time and wherein one or more layers of each of the implants are created at least in part by 3-D printing.

8. The implant according to claim 7 , wherein separation of the implants involves cutting, lasers, etching or mechanical devices.

9. The implant according to claim 8 , wherein the separation results in the creation of a large number of individual implants to increase yield or to reduce manufacturing expense.

10. The method according to claim 1 , wherein said sheet of prefabricated coating material comprises silicone.

11. The method according to claim 2 , wherein said matrix core layer comprises silicone.

12. The method according to claim 3 , wherein the implant includes a coating layer that comprises silicone.

Continuity (3)
Continuation 13796875 · Mar 12, 2013
Provisional Application 61709856 · Oct 4, 2012
Related Publication 20160067177A1 · Mar 10, 2016